Shares of Humana Inc. HUM slipped 4.41% to $253.77 Friday, on what proved to be an all-around grim trading session for the ...

Currently, Humana has a poor Growth Score of F, a grade with the same score on the momentum front. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for ...

Humana Inc. (NYSE: HUM) will release financial results for the first quarter 2025 (1Q25) and host a live question-and-answer ...

Humana’s (HUM) ongoing litigation with the Center for Medicaid & Medicaid Services on its Medicare Advantage Stars performance remains a ...

Humana’s outlook isn’t great, but performance in the fourth quarter ... privately-managed health scheme for older Americans. Humana stock has fallen roughly 40% since the start of 2023 as ...

Humana (HUM) stock is plunging in Wednesday's session ... Sign up "The decline in Stars performance for 2025 will impact Humana's quality bonus payments in 2026," Humana said in the filing.

HUM has been the topic of several other reports. TD Cowen lifted their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th.

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Shares of Humana Inc. HUM shed 1.82% to $264.58 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.97% to 5,580.94 and Dow ...

Humana leaders will present on the company’s strategic direction, operational and financial progress as well as expectations for future performance. For those unable to participate in the live ...